HOUSTON, TX, April 04, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office ...
Recent advances in non-invasive technologies have shown disruptive potential for biomedical applications. However, while surgically non-invasive, they may introduce other types of limitations which ...
Neuromodulation techniques are undoubtedly a crucial component of today’s Parkinson’s disease (PD) treatment, offering a valuable complement to conventional pharmacological therapies such as dopamine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results